Amphista Therapeutics Achieves Breakthrough in Cancer Target Degradation Amphista Therapeutics, a leader in next-generation targeted protein degradation (TPD), has published a study in Nat…
Bulls Shake Off Illness to Claim ALM Win Over Reds Macarthur FC have defeated Adelaide for their first victory of the A-League Men season,…
London Gateway Tech to Reduce Truck Waiting Times A new automated stacking system at London Gateway is set to improve truck turnaround tim…
Meralco's 9-Month Profit Increases by 14% Manila Electric Company (Meralco) reported a 14% increase in consolidated core net income, reach…
Scientists Say This 5-Minute Trick Could Help You Live Longer New research suggests it could be the key to boosting heart and lung health.…
Teachers Licensing Initiative to Uphold Education Standards The Botswana Teaching Professionals Councils (BOTEPCO) has launched a teacher …
Compulsory Voting: A Remedy or Ruse for Democracy? The debate over compulsory voting revolves around a trade-off between participation and…
Guard Therapeutics Announces Top-Line Results from Phase 2b POINTER Study Guard Therapeutics (publ) announced top-line results from the Ph…
US Navy Aircraft and Helicopter Crash in South China Sea Two US Navy aircraft and a helicopter crashed in separate incidents over the Sout…
FTSE Mixed as UK Lags Global Rally London stocks opened mixed on Monday, with the FTSE 100 edging up 0.1% to 9,651.66 as the UK market lag…
Hemab Secures $157M to Address 'Underserved' Blood Diseases Hemab, a startup with medicines in testing and development, aims to build the …